The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases

Based on research carried out over the last decade, it has become increasingly evident that bile acids act not only as detergents, but also as important signaling molecules that exert various biological effects via activation of specific nuclear receptors and cell signaling pathways. Bile acids also regulate the expression of numerous genes encoding enzymes and proteins involved in the synthesis and metabolism of bile acids, glucose, fatty acids, and lipoproteins, as well as energy metabolism. Receptors activated by bile acids include, farnesoid X receptor α, pregnane X receptor, vitamin D receptor, and G protein-coupled receptors, TGR5, muscarinic receptor 2, and sphingosine-1-phosphate receptor (S1PR)2. The ligand of S1PR2, sphingosine-1-phosphate (S1P), is a bioactive lipid mediator that regulates various physiological and pathophysiological cellular processes. We have recently reported that conjugated bile acids, via S1PR2, activate and upregulate nuclear sphingosine kinase 2, increase nuclear S1P, and induce genes encoding enzymes and transporters involved in lipid and sterol metabolism in the liver. Here, we discuss the role of bile acids and S1P signaling in the regulation of hepatic lipid metabolism and in hepatobiliary diseases.

[1]  M. Maceyka,et al.  Sphingosine‐1‐phosphate phosphatase 2 promotes disruption of mucosal integrity, and contributes to ulcerative colitis in mice and humans , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  M. Komatsu,et al.  DNA damage response and sphingolipid signaling in liver diseases , 2016, Surgery Today.

[3]  Runping Liu,et al.  Taurocholate Induces Cyclooxygenase-2 Expression via the Sphingosine 1-phosphate Receptor 2 in a Human Cholangiocarcinoma Cell Line* , 2015, The Journal of Biological Chemistry.

[4]  M. Maceyka,et al.  Spinster 2, a sphingosine‐1‐phosphate transporter, plays a critical role in inflammatory and autoimmune diseases , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  Hui-Young Lee,et al.  Activation of sphingosine kinase 2 by endoplasmic reticulum stress ameliorates hepatic steatosis and insulin resistance in mice , 2015, Hepatology.

[6]  S. Milstien,et al.  The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer , 2015, Oncogenesis.

[7]  S. Spiegel,et al.  Conjugated bile acid–activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression , 2015, Hepatology.

[8]  G. Alpini,et al.  Bile acid signaling and biliary functions , 2015, Acta pharmaceutica Sinica. B.

[9]  P. Hylemon,et al.  Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism , 2015, Acta pharmaceutica Sinica. B.

[10]  S. Spiegel,et al.  Uncleaved ApoM Signal Peptide Is Required for Formation of Large ApoM/Sphingosine 1-Phosphate (S1P)-enriched HDL Particles* , 2015, The Journal of Biological Chemistry.

[11]  Sarah Spiegel,et al.  Export of sphingosine-1-phosphate and cancer progression , 2014, Journal of Lipid Research.

[12]  S. Spiegel,et al.  Lysophospholipid receptor nomenclature review: IUPHAR Review 8 , 2014, British journal of pharmacology.

[13]  T. Hla,et al.  An update on the biology of sphingosine 1-phosphate receptors , 2014, Journal of Lipid Research.

[14]  T. Wakai,et al.  Sphingosine-1-Phosphate Transporters as Targets for Cancer Therapy , 2014, BioMed research international.

[15]  Cheng Luo,et al.  Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory , 2014, Nature Neuroscience.

[16]  Sarah Spiegel,et al.  Sphingolipid metabolites in inflammatory disease , 2014, Nature.

[17]  N. Hemdan,et al.  Sphingosine 1-Phosphate in Blood: Function, Metabolism, and Fate , 2014, Cellular Physiology and Biochemistry.

[18]  A. Yamaguchi,et al.  Molecular and physiological functions of sphingosine 1-phosphate transporters. , 2014, Biochimica et biophysica acta.

[19]  Todd Evans,et al.  Sphingosine 1-phosphate signalling , 2014, Development.

[20]  Junlin Qi,et al.  Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy , 2013, Disease Models & Mechanisms.

[21]  S. Milstien,et al.  Sphingosine-1-phosphate in chronic intestinal inflammation and cancer. , 2014, Advances in biological regulation.

[22]  S. Spiegel,et al.  Hepatic Apolipoprotein M (ApoM) Overexpression Stimulates Formation of Larger ApoM/Sphingosine 1-Phosphate-enriched Plasma High Density Lipoprotein* , 2013, The Journal of Biological Chemistry.

[23]  Y. Hannun,et al.  Sphingosine‐1‐phosphate receptor 2 , 2013, The FEBS journal.

[24]  Yuhuan Wang,et al.  Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice , 2013, Journal of Lipid Research.

[25]  K. Takabe,et al.  Emerging Role of Sphingosine-1-phosphate in Inflammation, Cancer, and Lymphangiogenesis , 2013, Biomolecules.

[26]  P. Edwards,et al.  Pleiotropic roles of bile acids in metabolism. , 2013, Cell metabolism.

[27]  Sarah Spiegel,et al.  Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  Hardik I. Parikh,et al.  Biological Characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a Selective Sphingosine Kinase-2 Inhibitor and Anticancer Agent , 2013, PloS one.

[29]  Eugene Y. Kim,et al.  Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. , 2013, Cancer cell.

[30]  J. Pfeilschifter,et al.  Evidence for a link between histone deacetylation and Ca²+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts. , 2012, The Biochemical journal.

[31]  Kazuaki Takabe,et al.  The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesis. , 2012, Lymphatic research and biology.

[32]  J. Cyster,et al.  Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. , 2012, Annual review of immunology.

[33]  Eugene Y. Kim,et al.  Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. , 2012, Cancer research.

[34]  S. Spiegel,et al.  Conjugated bile acids activate the sphingosine‐1‐phosphate receptor 2 in primary rodent hepatocytes , 2012, Hepatology.

[35]  Sarah Spiegel,et al.  Sphingosine-1-phosphate signaling and its role in disease. , 2012, Trends in cell biology.

[36]  Yinxin Zhang,et al.  Impact of bile acids on the growth of human cholangiocarcinoma via FXR , 2011, Journal of hematology & oncology.

[37]  S. Milstien,et al.  The outs and the ins of sphingosine-1-phosphate in immunity , 2011, Nature Reviews Immunology.

[38]  Charles D Smith,et al.  Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts , 2011, Cancer biology & therapy.

[39]  D. C. Simpson,et al.  Sphingosine‐1‐phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  Cheng Luo,et al.  SPHINGOSINE-1-PHOSPHATE: A MISSING COFACTOR FOR THE E3 UBIQUITIN LIGASE TRAF2 , 2010, Nature.

[41]  Lixin Sun,et al.  Bile acids regulate hepatic gluconeogenic genes and farnesoid X receptor via Gαi-protein-coupled receptors and the AKT pathway[S] , 2010, Journal of Lipid Research.

[42]  Sarah Spiegel,et al.  Estradiol Induces Export of Sphingosine 1-Phosphate from Breast Cancer Cells via ABCC1 and ABCG2* , 2010, The Journal of Biological Chemistry.

[43]  Ying Xu,et al.  Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning , 2009, The Journal of experimental medicine.

[44]  J. Chiang,et al.  Bile acids: regulation of synthesis , 2009, Journal of Lipid Research.

[45]  Cheng Luo,et al.  Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate , 2009, Science.

[46]  J. Auwerx,et al.  TGR5-mediated bile acid sensing controls glucose homeostasis. , 2009, Cell metabolism.

[47]  Timothy D Veenstra,et al.  Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation. , 2009, Genes & development.

[48]  S. Milstien,et al.  “Inside-Out” Signaling of Sphingosine-1-Phosphate: Therapeutic Targets , 2008, Pharmacological Reviews.

[49]  J. Liao,et al.  Distribution of sphingosine kinase activity and mRNA in rodent brain , 2007, Journal of neurochemistry.

[50]  T. Hla,et al.  Induction of Vascular Permeability by the Sphingosine-1-Phosphate Receptor–2 (S1P2R) and its Downstream Effectors ROCK and PTEN , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[51]  S. Milstien,et al.  Sphingosine Kinase Type 2 Activation by ERK-mediated Phosphorylation* , 2007, Journal of Biological Chemistry.

[52]  P. Dent,et al.  Conjugated Bile Acids Regulate Hepatocyte Glycogen Synthase Activity In Vitro and In Vivo via Gαi Signaling , 2007, Molecular Pharmacology.

[53]  S. Spiegel,et al.  Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin–sensitive mechanism in murine and human hepatocytes , 2005, Hepatology.

[54]  J. Wess,et al.  Deoxycholyltaurine-induced vasodilation of rodent aorta is nitric oxide- and muscarinic M(3) receptor-dependent. , 2005, European journal of pharmacology.

[55]  Jung-Hwan Yoon,et al.  Bile acids activate EGF receptor via a TGF-alpha-dependent mechanism in human cholangiocyte cell lines. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[56]  V. Puri,et al.  Sphingolipid Storage Induces Accumulation of Intracellular Cholesterol by Stimulating SREBP-1 Cleavage* , 2003, Journal of Biological Chemistry.

[57]  S. Milstien,et al.  Molecular Cloning and Functional Characterization of a Novel Mammalian Sphingosine Kinase Type 2 Isoform* , 2000, The Journal of Biological Chemistry.

[58]  M. Makishima,et al.  Identification of a nuclear receptor for bile acids. , 1999, Science.

[59]  J. Lehmann,et al.  Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.

[60]  Jasmine Chen,et al.  Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. , 1999, Molecular cell.

[61]  S. Glaser,et al.  Bile acids stimulate proliferative and secretory events in large but not small cholangiocytes. , 1997, The American journal of physiology.